Table 4 Factors related to six-month poor prognosis after acute intracerebral hemorrhage
Variables | mRS 3–6 | mRS 0–2 | P value |
|---|---|---|---|
Number | 58 | 68 | |
Age (years) | 62.1 ± 9.8 | 61.7 ± 10.6 | 0.822 |
Gender (male/female) | 28/30 | 41/27 | 0.177 |
Body mass index (kg/m2) | 24.1 ± 3.1 | 24.3 ± 3.6 | 0.792 |
Hypertension | 37 (63.8%) | 38 (55.9%) | 0.367 |
Diabetes mellitus | 14 (24.1%) | 17 (25.0%) | 0.911 |
Hyperlipidemia | 19 (32.8%) | 21 (30.9%) | 0.822 |
Coronary heart disease | 7 (12.1%) | 3 (4.4%) | 0.113 |
Cigarette smoking | 18 (31.0%) | 29 (42.7%) | 0.179 |
Alcohol drinking | 19 (32.8%) | 30 (44.1%) | 0.192 |
Statin use | 16 (27.6%) | 17 (25.0%) | 0.742 |
Anticoagulant use | 3 (5.2%) | 4 (5.9%) | 0.862 |
Antiplatelet use | 6 (10.3%) | 12 (17.7%) | 0.243 |
Antihypertensive use | 32 (55.2%) | 35 (51.5%) | 0.678 |
Hypoglycemic use | 12 (20.7%) | 13 (19.1%) | 0.825 |
Admission time (h) | 9.2 (6.8–12.4) | 8.9 (4.8–14.7) | 0.862 |
Sampling time (h) | 10.9 (8.3–14.6) | 10.4 (6.5–16.4) | 0.818 |
Systolic arterial pressure (mmHg) | 140.3 ± 23.2 | 145.1 ± 22.8 | 0.243 |
Diastolic arterial pressure (mmHg) | 85.3 ± 10.0 | 86.1 ± 9.6 | 0.638 |
Hemorrhage locations (lobar/deep) | 17/41 | 16/52 | 0.462 |
Intraventricular hemorrhage | 20 (34.5%) | 11 (16.2%) | 0.017 |
Subarachnoidal hemorrhage | 9 (15.5%) | 2 (2.9%) | 0.013 |
NIHSS scores | 11 (11–13) | 8 (4–10) | < 0.001 |
Hematoma volume (ml) | 21 (13–28) | 9 (6–15) | < 0.001 |
Blood leucocyte count (×109/l) | 8.3 (6.2–10.9) | 7.9 (6.3–9.4) | 0.829 |
Blood glucose levels (mmol/l) | 12.9 (9.5–17.1) | 10.8 (9.2–12.3) | 0.014 |
Serum sestrin2 levels (ng/ml) | 13.7 (4.7–23.0) | 3.6 (2.4–7.3) | < 0.001 |